SAMSARA BIOCAPITAL, LLC
CIK 1744967
13F filing for Q2 2026・No. 2,261
- Holdings
- US$1.22B
- Quarter change
- +US$188.36M
- Entries
- 24
- Net bought (estimate)
- +US$80.78M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 4
- Sold out 2
- Cut 5
- Added 2
- Corporate actions 0
- Unchanged 13
Largest holdings
24 stocks worth US$1.22B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| SCHOLAR ROCK HLDG CORPCOM | Unchanged | 6,897,652 | US$379.37M | 31.16% |
| ALUMIS INCCOM | Unchanged | 6,345,219 | US$178.55M | 14.67% |
| MINERALYS THERAPEUTICS INCCOM | Unchanged | 5,871,018 | US$158.4M | 13.01% |
| SEPTERNA INCCOM | Unchanged | 3,149,128 | US$105.46M | 8.66% |
| ALMRALAMAR BIOSCIENCES INCCOMMON STOCK | New | 2,480,310 | US$67.19M | 5.52% |
| NEUROGENE INCCOM | Unchanged | 1,717,127 | US$54M | 4.44% |
| KALARIS THERAPEUTICS INCCOM | Cut | 12,881,175 | US$52.43M | 4.31% |
| SPYGLASS PHARMA INCCOM SHS | Unchanged | 2,109,953 | US$46.97M | 3.86% |
| SUTRO BIOPHARMA INCCOM SHS | Unchanged | 1,062,872 | US$35.29M | 2.90% |
| INVENTIVA SAADS | Added | 6,314,805 | US$23.87M | 1.96% |
Sign in (free) to see its 24 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.